MERCAPTOPURINE PHARMACOGENETICS - MONOGENIC INHERITANCE OF ERYTHROCYTE THIOPURINE METHYLTRANSFERASE ACTIVITY

被引：5
|
作者：
WEINSHILBOUM, RM [1 ]
SLADEK, SL [1 ]
机构：
[1] MAYO CLIN & MAYO FDN,SCH MED,DEPT INTERNAL MED,ROCHESTER,MN 55901
来源：
AMERICAN JOURNAL OF HUMAN GENETICS | 1980年 / 32卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
引用
收藏
页码：651 / 662
页数：12
相关论文
共 50 条
  • [21] Pharmacogenetics of thiopurine methyltransferase:: genotype vs phenotype
    Fauset, A
    Wilson, G
    Otterness, D
    Vora, A
    Lennard, L
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 47 (05) : 597 - 597
  • [22] MOUSE THIOPURINE METHYLTRANSFERASE PHARMACOGENETICS - CORRELATION OF IMMUNOREACTIVE PROTEIN AND ENZYMATIC-ACTIVITY
    HERNANDEZ, JS
    VANLOON, JA
    OTTERNESS, DM
    WEINSHILBOUM, RM
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1990, 252 (02): : 568 - 573
  • [23] HUMAN-LYMPHOCYTE THIOPURINE METHYLTRANSFERASE PHARMACOGENETICS - EFFECT OF PHENOTYPE ON 6-MERCAPTOPURINE-INDUCED INHIBITION OF MITOGEN STIMULATION
    VANLOON, JA
    WEINSHILBOUM, RM
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1987, 242 (01): : 21 - 26
  • [24] Azathioprine and diffuse alveolar haemorrhage: the pharmacogenetics of thiopurine methyltransferase
    Perri, D.
    Cole, D. E. C.
    Friedman, O.
    Piliotis, E.
    Mintz, S.
    Adhikari, N. K. J.
    EUROPEAN RESPIRATORY JOURNAL, 2007, 30 (05) : 1014 - 1017
  • [25] PHARMACOGENETICS OF THIOPURINE METHYLTRANSFERASE IN TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIAWITH 6-MERCAPTOPURINE IN TURKISH CHILDREN-DISCORDANT CASES
    Arinc, E.
    Tumer, T. B.
    Gurses, S.
    Ulusoy, G.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 55 - 56
  • [26] Should thiopurine methyltransferase (TPMT) activity be determined before prescribing azathioprine, mercaptopurine, or thioguanine?
    DiPiero, Jennifer
    Teng, Kathryn
    Hicks, J. Kevin
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2015, 82 (07) : 409 - 413
  • [27] Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing
    Relling, M. V.
    Gardner, E. E.
    Sandborn, W. J.
    Schmiegelow, K.
    Pui, C-H
    Yee, S. W.
    Stein, C. M.
    Carrillo, M.
    Evans, W. E.
    Klein, T. E.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (03) : 387 - 391
  • [28] Thiopurine methyltransferase (TPMT) pharmacogenetics: Polymorphism characterization.
    Otterness, D
    Szumlanski, C
    Wood, T
    Lennard, L
    Klemetsdal, B
    Aarbakke, J
    ParkHah, J
    Iven, H
    Branum, E
    OBrien, J
    Weinshilboum, R
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (02) : OIB4 - OIB4
  • [29] Human thiopurine methyltransferase pharmacogenetics: Gene sequence polymorphisms
    Otterness, D
    Szumlanski, C
    Lennard, L
    Klemetsdal, B
    Aarbakke, J
    ParkHah, JO
    Iven, H
    Schmiegelow, K
    Branum, E
    OBrien, J
    Weinshilboum, R
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 62 (01) : 60 - 73
  • [30] HUMAN LIVER THIOPURINE METHYLTRANSFERASE PHARMACOGENETICS - BIOCHEMICAL-PROPERTIES, LIVER-ERYTHROCYTE CORRELATION AND PRESENCE OF ISOZYMES
    SZUMLANSKI, CL
    HONCHEL, R
    SCOTT, MC
    WEINSHILBOUM, RM
    PHARMACOGENETICS, 1992, 2 (04): : 148 - 159
12345